調查批次:CHT2016-02 | 檢體寄出日期:2016-04-18 | 報告回收截止日期:2016-04-25 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 4 |
2 |
5 |
1.71 |
-0.12 |
-6.6 |
-0.8 |
0.2 |
-27 |
2.63 |
-0.23 |
-8.0 |
-1.0 |
0.1 |
-33 |
RH07b | RH07 | 8 |
2 |
3 |
1.74 |
-0.09 |
-4.9 |
-0.6 |
0.4 |
-20 |
3.21 |
0.35 |
12.2 |
1.5 |
1.2 |
51 |
RH14 | RH14 | 7 |
2 |
3 |
1.76 |
-0.07 |
-3.8 |
-0.5 |
0.5 |
-16 |
2.81 |
-0.05 |
-1.7 |
-0.2 |
0.4 |
-7 |
RH15 | RH15 | 7 |
2 |
5 |
1.50 |
-0.33 |
-18.0 |
-2.2 |
-1.1 |
-73 |
2.10 |
-0.76 |
-26.6 |
-3.3 |
-1.0 |
-110 |
CL009 | CL009 | 3 |
2 |
5 |
1.37 |
-0.46 |
-25.1 |
-3.1 |
-1.9 |
-102 |
2.06 |
-0.80 |
-28.0 |
-3.5 |
-1.0 |
-116 |
CL010 | CL010 | 3 |
2 |
5 |
1.65 |
-0.18 |
-9.8 |
-1.2 |
-0.2 |
-40 |
2.28 |
-0.58 |
-20.3 |
-2.5 |
-0.6 |
-84 |
CL012 | CL012 | 7 |
2 |
3 |
1.82 |
-0.01 |
-0.5 |
-0.1 |
0.9 |
-2 |
3.20 |
0.34 |
11.9 |
1.5 |
1.2 |
49 |
CL013 | CL013 | 4 |
2 |
5 |
1.61 |
-0.22 |
-12.0 |
-1.5 |
-0.4 |
-49 |
2.22 |
-0.64 |
-22.4 |
-2.8 |
-0.7 |
-93 |
CL015 | CL015 | 4 |
2 |
3 |
1.86 |
0.03 |
1.6 |
0.2 |
1.1 |
7 |
2.84 |
-0.02 |
-0.7 |
-0.1 |
0.5 |
-3 |
Median of RIA Group |
1.71 |
2.63 |
||||||||||||||
Range of RIA Group |
1.37 - 1.86 |
2.06 - 3.21 |
||||||||||||||
Robust mean of RIA Group |
1.68 ( n = 9 ) |
2.59 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.16 |
0.51 |
||||||||||||||
CV of RIA Group |
9.5% |
19.7% |
||||||||||||||
Median of European RIA Labs |
1.71 ( n = 104 ) |
2.46 ( n = 103 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.59 - 1.90 |
2.24 - 2.84 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 1 |
4 |
9 |
1.98 |
0.15 |
8.2 |
1.0 |
1.1 |
33 |
2.94 |
0.08 |
2.8 |
0.3 |
0.7 |
12 |
RH02c | RH02 | 2 |
4 |
1 |
1.53 |
-0.30 |
-16.4 |
-2.0 |
-0.5 |
-67 |
2.12 |
-0.74 |
-25.9 |
-3.2 |
-1.4 |
-107 |
RH06 | RH06 | 1 |
4 |
9 |
1.95 |
0.12 |
6.6 |
0.8 |
1.0 |
27 |
3.11 |
0.25 |
8.7 |
1.1 |
1.1 |
36 |
RH07a | RH07 | 3 |
4 |
2 |
1.44 |
-0.39 |
-21.3 |
-2.6 |
-0.9 |
-87 |
2.61 |
-0.25 |
-8.7 |
-1.1 |
-0.2 |
-36 |
RH12 | RH12 | 4 |
4 |
2 |
1.53 |
-0.30 |
-16.4 |
-2.0 |
-0.5 |
-67 |
2.62 |
-0.24 |
-8.4 |
-1.0 |
-0.1 |
-35 |
RH19 | RH19 | 1 |
4 |
2 |
1.47 |
-0.36 |
-19.7 |
-2.4 |
-0.7 |
-80 |
2.44 |
-0.42 |
-14.7 |
-1.8 |
-0.6 |
-61 |
RH20 | RH20 | 7 |
4 |
7 |
1.52 |
-0.31 |
-16.9 |
-2.1 |
-0.6 |
-69 |
2.53 |
-0.33 |
-11.5 |
-1.4 |
-0.4 |
-48 |
CL005 | CL005 | 2 |
4 |
9 |
2.10 |
0.27 |
14.8 |
1.8 |
1.6 |
60 |
3.20 |
0.34 |
11.9 |
1.5 |
1.3 |
49 |
CL006a | CL006 | 4 |
4 |
7 |
1.54 |
-0.29 |
-15.8 |
-1.9 |
-0.5 |
-64 |
2.55 |
-0.31 |
-10.8 |
-1.3 |
-0.3 |
-45 |
CL008 | CL008 | 4 |
4 |
2 |
1.51 |
-0.32 |
-17.5 |
-2.1 |
-0.6 |
-71 |
2.75 |
-0.11 |
-3.8 |
-0.5 |
0.2 |
-16 |
CL011 | CL011 | 1 |
4 |
13 |
1.95 |
0.12 |
6.6 |
0.8 |
1.0 |
27 |
3.05 |
0.19 |
6.6 |
0.8 |
1.0 |
28 |
CL014b | CL014 | 3 |
4 |
1 |
1.55 |
-0.28 |
-15.3 |
-1.9 |
-0.4 |
-62 |
2.13 |
-0.73 |
-25.5 |
-3.2 |
-1.4 |
-106 |
Median of CLIA Group |
1.54 |
2.62 |
||||||||||||||
Range of CLIA Group |
1.44 - 2.10 |
2.12 - 3.20 |
||||||||||||||
Robust mean of CLIA Group |
1.67 ( n = 12 ) |
2.67 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.27 |
0.40 |
||||||||||||||
CV of CLIA Group |
16.2% |
15.0% |
||||||||||||||
Median of European CLIA Labs |
1.85 ( n = 1056 ) |
2.93 ( n = 1026 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.48 - 1.97 |
2.22 - 3.14 |
||||||||||||||
Median of All Labs |
1.61 |
2.62 |
||||||||||||||
Range of All Labs |
1.37 - 2.10 |
2.06 - 3.21 |
||||||||||||||
Robust mean of All Labs |
1.67 ( n = 21 ) |
2.64 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.22 |
0.44 |
||||||||||||||
CV of All Labs |
13.2% |
16.7%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.83 |
2.86 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.48 - 1.97 |
2.24 - 3.14 |
||||||||||||||
Mean of All European Labs |
1.75 ( n = 1216 ) |
2.74 ( n = 1197 ) |
||||||||||||||
SD of All European Labs |
0.228 |
0.436 |
||||||||||||||
CV of All European Labs |
13.0% |
16.0% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.146 |
0.229 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2016-04-26